scholarly article | Q13442814 |
P50 | author | Winfried B. Graninger | Q38639365 |
Franz Fazekas | Q43184302 | ||
Thomas Gattringer | Q47868316 | ||
Michael Khalil | Q57021488 | ||
Alexander Pichler | Q103833264 | ||
Christian Enzinger | Q114270415 | ||
P2093 | author name string | Johannes Haybaeck | |
Petra Schwingenschuh | |||
Christina Ernst | |||
Alexander Moser | |||
P2860 | cites work | Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring | Q28243804 |
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. | Q30583907 | ||
PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section | Q30613846 | ||
Risk of natalizumab-associated progressive multifocal leukoencephalopathy | Q34275329 | ||
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease | Q37381059 | ||
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada | Q43218822 | ||
P433 | issue | 1 | |
P921 | main subject | multiple sclerosis | Q8277 |
P304 | page(s) | e1 | |
P577 | publication date | 2014-04-24 | |
P1433 | published in | Neurology(R) neuroimmunology & neuroinflammation | Q27725776 |
P1476 | title | Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy | |
P478 | volume | 1 |
Q34368573 | Gathering thunder | cites work | P2860 |
Search more.